Impact Factor 3.519

Frontiers journals are at the top of citation and impact metrics

General Commentary ARTICLE

Front. Endocrinol., 09 June 2015 | https://doi.org/10.3389/fendo.2015.00098

Corrigendum: “Cancer cell gene expression modulated from plasma membrane integrin αvβ3 by thyroid hormone and nanoparticulate tetrac”

imagePaul J. Davis1,2*, imageGennadi V. Glinsky3, imageHung-Yun Lin4, imageJohn T. Leith5, imageAleck Hercbergs6, imageHeng-Yuan Tang2, imageOsnat Ashur-Fabian7,8, imageSandra Incerpi9 and imageShaker A. Mousa2
  • 1Department of Medicine, Albany Medical College, Albany, NY, USA
  • 2Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA
  • 3Stanford University, Palo Alto, CA, USA
  • 4Taipei Medical University, Taipei, Taiwan
  • 5Rhode Island Nuclear Science Center, Narragansett, RI, USA
  • 6Cleveland Clinic, Cleveland, OH, USA
  • 7Hematology Institute and Blood Bank, Meir Medical Center, Kfar-Saba, Israel
  • 8Department of Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  • 9Department of Sciences, University Roma Tre, Rome, Italy

A corrigendum on

Cancer cell gene expression modulated from plasma membrane integrin αvβ3 by thyroid hormone and nanoparticulate tetrac
by Davis PJ, Glinsky GV, Lin H-Y, Leith JT, Hercbergs A, Tang H-Y, et al. Front Endocrinol (2015) 5:240. doi: 10.3389/fendo.2014.00240

In Table 2, the section designated “Disabling of cell survival pathway gene expression,” line 5 incorrectly states “…pro-apoptotic miR-21”; the correct statement is “…pro-apoptotic miR-15A.” The issue is correctly discussed in the body of the published text, p. 2, right column, paragraph 4.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: integrin, thyroid hormone, tetraiodothyroacetic acid (tetrac), nano particle, gene expression, corrigendum

Citation: Davis PJ, Glinsky GV, Lin H-Y, Leith JT, Hercbergs A, Tang H-Y, Ashur-Fabian O, Incerpi S and Mousa SA (2015) Corrigendum: “Cancer cell gene expression modulated from plasma membrane integrin αvβ3 by thyroid hormone and nanoparticulate tetrac”. Front. Endocrinol. 6:98. doi: 10.3389/fendo.2015.00098

Received: 27 May 2015; Accepted: 27 May 2015;
Published: 09 June 2015

Edited by:

Wen Zhou, Columbia University, USA

Reviewed by:

Jean-Yves Scoazec, Université Lyon 1, France

Copyright: © 2015 Davis, Glinsky, Lin, Leith, Hercbergs, Tang, Ashur-Fabian, Incerpi and Mousa. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Paul J. Davis, pdavis.ordwayst@gmail.com